Status:
RECRUITING
Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL)
Lead Sponsor:
University Health Network, Toronto
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study is being done to help further understand how MR-guided adaptive RT in conjunction with the Integrated Magnetic Resonance Linear Accelerator (MRL) can improve patient outcomes. This study wi...
Eligibility Criteria
Inclusion
- Patients 18 years or older with a diagnosis of cancer, regardless of clinical site or stage
- Planned to receive a course of MR-guided adaptive RT using the MRL
- Ability to provide informed consent
Exclusion
- Patients under 18 years old
Key Trial Info
Start Date :
December 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04135794
Start Date
December 9 2019
End Date
November 30 2026
Last Update
June 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Centre
Toronto, Ontario, Canada, M5G 2M9